Rapport Therapeutics, Inc. ($RAPP)
Filing Information
| Accession Number | 0001193125-26-154908 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 14, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
19,865
Total Value
$695,823.33
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer | Common Stock | โ | Apr 10, 2026 | Sale | 500 | $34.98 | $17,490.00 | 286,016 | Direct | โ | View Details | |
Chief Development Officer | Common Stock | โ | Apr 13, 2026 | Sale | 9,165 | $34.97 | $320,536.71 | 276,851 | Direct | โ | View Details | |
Chief Development Officer | Common Stock | โ | Apr 14, 2026 | Sale | 10,200 | $35.08 | $357,796.62 | 266,651 | Direct | โ | View Details |